Skip to main content
. 2023 Jul 10;88(14):9910–9919. doi: 10.1021/acs.joc.3c00673

Scheme 2. Use of In Situ-Formed Hexahydropyrimidines for Modulation of the Peptide Structure.

Scheme 2